Skip to content
Neuronet
Neuronet - The support action for EU research on neurodegeneration
  • ABOUT
        • Objectives
        • Glossary
        • Work Packages
        • Partners
        • Executive Committee
        • Task Forces
        • Working Groups
        • Scientific Coordination Board
  • EVENTS
        • 2021: Virtual event
        • 2020: Virtual Event
        • 2019: The Hague
        • Event Calendar
  • NEWS
        • Latest news
        • Neuronet newsletters
        • Neuronet in the Media
  • PROJECTS
        • Ongoing Projects
        • Completed Projects
        • Project Overview
        • Project Timescales
  • RESOURCES
        • Asset Map
        • Project Tools
        • Regulatory & HTA Decision Tool
        • Neuronet Tools
        • Neuronet Deliverables
        • Neuronet Presentations
        • Publications
        • Useful resources for young researchers
  • KNOWLEDGE BASE

Sin categoría

Spotlight on early-career researchers: a Neuronet interview with Alison Keogh

25th October 2021
Alison Keogh - UCD - Mobilise-D Spotlight on early-career researchers: a Neuronet interview with Alison Keogh

In this spotlight on early-career researchers interview, we speak with Alison Keogh. Alison works as

Neuronet convenes 7th meeting of its Scientific Coordination Board

10th January 202222nd October 2021
SCB update

On 21 October, the Innovative Medicines Initiative (IMI) funded Neuronet Coordination and Support Action convened

Tackling the replication crisis in neuroscience

9th February 202215th October 2021
EQIPD - European Quality In Preclinical Data

The European Quality in Preclinical Data (EQIPD) consortium has announced the official finalisation of the

Neuronet hosts an online meeting of its Data Sharing working group

8th November 202114th October 2021

On 14 October 2021, Neuronet convened an online meeting of its data sharing Working Group

Spotlight on early-career researchers: a Neuronet interview with Hannah Scheiblich

7th March 202213th October 2021
Spotlight on early-career researchers: a Neuronet interview with Hannah Scheiblich

In this Neuronet interview, we speak with Hannah Scheiblich. Hannah works as a postdoctoral researcher on

Biosamples from people with Alzheimer’s disease, Mild Cognitive Impairment or healthy individuals accessible for research purposes

22nd October 202112th October 2021
DNA string

The Innovative Medicines Initiative funded ADAPTED project aimed to support the development of new medicines

The Relevance of Ensuring Networking and Collaborative Work

12th October 202112th October 2021
Neuronet evaluation results

At the beginning of October, Alzheimer Europe and Neuronet co-hosted a European Parliament workshop entitled:

Learnings from involving people with dementia, mild cognitive impairment & carers

18th October 202112th October 2021
RADAR-AD Remote assessment of disease and relapse – Alzheimer’s disease

On 7 October, the funder of the RADAR-AD project – the Innovative Medicines Initiative (IMI),

Open position as Sustainability & Commercialisation Manager for the European Platform for Neurodegenerative Disorders

11th October 2021

Reporting to senior management, the Sustainability & Commercialisation Manager (SCM) will be co-responsible for the

IDEA-FAST qualification advice request submitted to the European Medicines Agency

11th October 2021

On 27 Sep 2021, the Innovative Medicines Initative Consortium IDEA-FAST submitted a request for an

Post navigation
Older posts
Newer posts
← Previous Page1 … Page8 Page9 Page10 … Page29 Next →

LATEST NEWS

  • Neuronet publishes Frontiers in Neurology article, analysing the structure, assets and collaborative networks in the IMI neurodegeneration portfolio

    9th November 2022
    The Innovative Medicines Initiative (IMI) was launched in 2008, with an initial budget of €8bn.Read More
  • Spotlight on Early-Career researchers a Neuronet interview with Ilja Saris

    5th September 2022
    In this Neuronet spotlight on early-career researcher interview, we speak with Ilja Saris who worksRead More
  • Spotlight on Communication experts: A Neuronet Blog with Cindy Birck

    29th August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More
  • Webinar series: Mobilise-D presents its four patient cohorts

    25th August 2022
    Mobilise-D starts the autumn webinar series presenting the needs, technologies, protocols and user perspectives forRead More
  • Spotlight on Communication experts: A Neuronet Blog with Yoanna de Geus

    23rd August 2022
    Neuronet is a Coordination and Support Action for the Innovative Medicines Initiative’s research projects onRead More

Neuronet

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 821513. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Parkinson’s UK.

Any information on this website solely reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

 

 

Innovative Medicines InitiativeEU Flag logoEuropean Federation of Pharmaceutical Industries and Associations logoParksinson's UK logo

Disclaimer
About IMI
Legal notice
Privacy policy

@ 2019 – IMI-NEURONET

© 2026 - IMI-NEURONET
We use cookies to offer you a better browsing experience and to analyze site traffic. Read about how we use cookies and how you can control them in our Cookie Policy. If you continue to use this site, you consent to our use of cookies. AcceptCookie policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT